Literature DB >> 14691434

Importance of echocardiography in patients with severe nonischemic heart failure: the second Prospective Randomized Amlodipine Survival Evaluation (PRAISE-2) echocardiographic study.

Christopher H Cabell1, Benjamin H Trichon, Eric J Velazquez, Jean G Dumesnil, Kevin J Anstrom, Thomas Ryan, Alan B Miller, Robert N Belkin, Anne B Cropp, Christopher M O'Connor, James G Jollis.   

Abstract

BACKGROUND: Echocardiography is used commonly in clinical practice when caring for patients with heart failure. It is unknown whether the presence of certain findings provides an incremental ability to predict survival beyond the use of baseline clinical findings alone. The second PRAISE-2 echocardiographic study was prospectively designed to identify echocardiographic predictors of survival among patients with nonischemic cardiomyopathy and heart failure and to determine if components of the echocardiographic examination add prognostic information to baseline demographic and clinical information.
METHODS: One hundred patients participated in the second Prospective Randomized Amlodipine Survival Evaluation Study (PRAISE-2) echocardiographic study; of these, 93 had full and interpretable echocardiographic examinations. Cox proportional hazards modeling was used to assess the relation between various characteristics and survival as well as to assess the incremental prognostic information gained by echocardiography beyond the clinical examination.
RESULTS: Seven of 10 routine echocardiographic measures were significantly associated with death. These included mitral regurgitation (hazard ratio [HR], 2.31; 95% CI, 1.02, 5.27), left ventricular ejection fraction <20% (HR, 2.59; 95% CI, 1.14, 5.88), restrictive left ventricular filling pattern (HR, 2.37; 95% CI, 1.05, 5.32), and peak D velocity (HR, 1.62; 95% CI, 0.38, 0.87). The only statistically significant clinical predictor of survival was dyspnea at rest. The addition any of several echocardiographic parameters to baseline clinical information significantly improved the ability to predict survival.
CONCLUSIONS: Several readily available echocardiographic parameters are predictive of death and when added to clinical examination findings significantly improve the ability to determine prognosis among patients with nonischemic cardiomyopathy and heart failure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14691434     DOI: 10.1016/j.ahj.2003.07.010

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

Review 1.  Advances in the surgical treatment of heart failure.

Authors:  Larry A Allen; G Michael Felker
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

2.  Mitral insufficiency and morbidity and mortality in left ventricular dysfunction.

Authors:  Roger J F Baskett; Derek V Exner; Gregory M Hirsch; William A Ghali
Journal:  Can J Cardiol       Date:  2007-08       Impact factor: 5.223

3.  Pharmacological interventions for heart failure in people with chronic kidney disease.

Authors:  Meaghan Lunney; Marinella Ruospo; Patrizia Natale; Robert R Quinn; Paul E Ronksley; Ioannis Konstantinidis; Suetonia C Palmer; Marcello Tonelli; Giovanni Fm Strippoli; Pietro Ravani
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

4.  Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trial.

Authors:  Janusz Lipiecki; Tomasz Siminiak; Horst Sievert; Jochen Müller-Ehmsen; Hubertus Degen; Justina C Wu; Christian Schandrin; Piotr Kalmucki; Ilona Hofmann; David Reuter; Steven L Goldberg; Michael Haude
Journal:  Open Heart       Date:  2016-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.